H-Index & Metrics Best Publications

H-Index & Metrics

Discipline name H-index Citations Publications World Ranking National Ranking
Biology and Biochemistry D-index 87 Citations 30,837 403 World Ranking 1244 National Ranking 22
Medicine D-index 93 Citations 28,207 422 World Ranking 5066 National Ranking 146

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Cancer
  • Enzyme

Gert Storm spends much of his time researching Liposome, Pharmacology, In vivo, Targeted drug delivery and Drug delivery. His study in Liposome is interdisciplinary in nature, drawing from both Pathology, Immunology, Arthritis and Biodistribution. The concepts of his Pharmacology study are interwoven with issues in Prednisolone, Polyethylene glycol and Chemotherapy, Doxorubicin.

Gert Storm interconnects Cancer research, In vitro, Cancer cell, Biophysics and Fluorescence microscope in the investigation of issues within In vivo. The study incorporates disciplines such as Micelle, Controlled release, Receptor, Theranostic Nanomedicine and Nanomedicine in addition to Targeted drug delivery. In general Drug delivery, his work in Drug carrier is often linked to Methacrylamide linking many areas of study.

His most cited work include:

  • Endosomal escape pathways for delivery of biologicals (908 citations)
  • Cancer siRNA therapy by tumor selective delivery with ligand-targeted sterically stabilized nanoparticle (855 citations)
  • Surface modification of nanoparticles to oppose uptake by the mononuclear phagocyte system (738 citations)

What are the main themes of his work throughout his whole career to date?

Gert Storm focuses on Liposome, Pharmacology, In vivo, Drug delivery and Cancer research. His Liposome study combines topics from a wide range of disciplines, such as Immunology, Biophysics, Drug carrier and Biodistribution. His Pharmacology research is multidisciplinary, relying on both Inflammation and Doxorubicin.

His In vivo study integrates concerns from other disciplines, such as Molecular biology, In vitro and Pathology. The Drug delivery study combines topics in areas such as Therapeutic index, Microbubbles, Micelle and Nanomedicine. His Cancer research research incorporates themes from Tumor microenvironment, Cancer, Immune system and Hepatic stellate cell.

He most often published in these fields:

  • Liposome (47.20%)
  • Pharmacology (35.68%)
  • In vivo (30.08%)

What were the highlights of his more recent work (between 2018-2021)?

  • Cancer research (19.68%)
  • In vivo (30.08%)
  • Drug delivery (24.64%)

In recent papers he was focusing on the following fields of study:

Cancer research, In vivo, Drug delivery, Immune system and Liposome are his primary areas of study. His Cancer research research incorporates elements of Chemotherapy, Doxorubicin, Hepatic stellate cell, Tumor microenvironment and Fibrosis. As part of one scientific family, Gert Storm deals mainly with the area of In vivo, narrowing it down to issues related to the In vitro, and often Polymersome.

His work carried out in the field of Drug delivery brings together such families of science as Clinical trial, Surgery, Cataract surgery, Chemical engineering and Biomedical engineering. His research integrates issues of Cancer, Drug, Macrophage and Antigen in his study of Immune system. His biological study spans a wide range of topics, including Ex vivo, Bortezomib, Hyperthermia, Clonogenic assay and Pharmacology.

Between 2018 and 2021, his most popular works were:

  • The role of liposomes in clinical nanomedicine development. What now? Now what? (51 citations)
  • Dexamethasone nanomedicines for COVID-19. (40 citations)
  • Dexamethasone nanomedicines for COVID-19. (40 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Cancer
  • Enzyme

His primary areas of investigation include In vivo, Cancer research, Drug, Pharmacology and Drug delivery. Gert Storm has included themes like Pharmacokinetics, Liposome, Nuclear medicine, Vascular permeability and Noninvasive imaging in his In vivo study. Gert Storm has researched Liposome in several fields, including Proteasome inhibitor, Ex vivo, Biodistribution, Therapeutic index and Bortezomib.

His Cancer research research is multidisciplinary, incorporating perspectives in In vitro, Chemotherapy, Hepatic stellate cell, Transferrin receptor and Bone marrow. He works mostly in the field of Pharmacology, limiting it down to topics relating to Immune system and, in certain cases, Drug carrier, Chronic liver disease, Fibrosis and Macrophage. The various areas that Gert Storm examines in his Drug delivery study include Adjuvant, Thrombus, Radiology and Photothermal therapy.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Endosomal escape pathways for delivery of biologicals

Amir K. Varkouhi;Marije Scholte;Gert Storm;Hidde J. Haisma.
Journal of Controlled Release (2011)

1237 Citations

Cancer siRNA therapy by tumor selective delivery with ligand-targeted sterically stabilized nanoparticle

Raymond M. Schiffelers;Aslam Ansari;Jun Xu;Qin Zhou.
Nucleic Acids Research (2004)

1122 Citations

Surface modification of nanoparticles to oppose uptake by the mononuclear phagocyte system

Gert Storm;Sheila O. Belliot;Toos Daemen;Danilo D. Lasic.
Advanced Drug Delivery Reviews (1995)

1061 Citations

Polymeric Micelles in Anticancer Therapy: Targeting, Imaging and Triggered Release

Chris Oerlemans;Wouter Bult;Mariska Bos;Gert Storm.
Pharmaceutical Research (2010)

782 Citations

In situ gelling hydrogels for pharmaceutical and biomedical applications.

Sophie R. Van Tomme;Gert Storm;Wim E. Hennink.
International Journal of Pharmaceutics (2008)

596 Citations

Tumour-targeted nanomedicines: principles and practice.

T.G.G.M. Lammers;W.E. Hennink;G. Storm.
British Journal of Cancer (2008)

585 Citations

Quantum dots with a paramagnetic coating as a bimodal molecular imaging probe

Willem J. M. Mulder;Rolf Koole;Ricardo J. Brandwijk;Gert Storm.
Nano Letters (2006)

558 Citations

Sheddable Coatings for Long-Circulating Nanoparticles

Birgit Romberg;Wim E. Hennink;Gert Storm.
Pharmaceutical Research (2008)

558 Citations

Accelerated Blood Clearance and Altered Biodistribution of Repeated Injections of Sterically Stabilized Liposomes

Els T. M. Dams;Peter Laverman;Wim J. G. Oyen;Gert Storm.
Journal of Pharmacology and Experimental Therapeutics (2000)

536 Citations

Specific targeting with poly(ethylene glycol)-modified liposomes: coupling of homing devices to the ends of the polymeric chains combines effective target binding with long circulation times

G. Blume;G. Cevc;M.D.J.A. Crommelin;I.A.J.M. Bakker-Woudenberg.
Biochimica et Biophysica Acta (1993)

442 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Gert Storm

Wim E. Hennink

Wim E. Hennink

Utrecht University

Publications: 156

Twan Lammers

Twan Lammers

RWTH Aachen University

Publications: 148

Vladimir P. Torchilin

Vladimir P. Torchilin

Northeastern University

Publications: 115

Zahi A. Fayad

Zahi A. Fayad

Icahn School of Medicine at Mount Sinai

Publications: 81

Fabian Kiessling

Fabian Kiessling

RWTH Aachen University

Publications: 71

Xiaoyuan Chen

Xiaoyuan Chen

National University of Singapore

Publications: 65

Patrick Couvreur

Patrick Couvreur

University of Paris-Saclay

Publications: 64

Ernst Wagner

Ernst Wagner

Ludwig-Maximilians-Universität München

Publications: 63

Yechezkel Barenholz

Yechezkel Barenholz

Hebrew University of Jerusalem

Publications: 60

Raymond M. Schiffelers

Raymond M. Schiffelers

Utrecht University

Publications: 57

Zhiyuan Zhong

Zhiyuan Zhong

Soochow University

Publications: 56

Robert Langer

Robert Langer

MIT

Publications: 55

Cornelus F. van Nostrum

Cornelus F. van Nostrum

Utrecht University

Publications: 54

Kazunori Kataoka

Kazunori Kataoka

University of Tokyo

Publications: 53

Vladimir R. Muzykantov

Vladimir R. Muzykantov

University of Pennsylvania

Publications: 53

Omid C. Farokhzad

Omid C. Farokhzad

Harvard Medical School

Publications: 48

Something went wrong. Please try again later.